The following steps are provided to assist investigators with submitting applications to the FIU IBC for review and approval.
 |
IBC approval is required for all research involving Recombinant, Synthetic Nucleic Acid molecules or DNA or RNA derived from Synthetic Nucleic Acid Molecules. Please see the definitions below.
Recombinant DNA
- DNA in which one or more segments or genes have been inserted, either naturally or by laboratory manipulation, from a different molecule or from another part of the same molecule, resulting in a new genetic combination.
- DNA molecules that are extracted from different sources and chemically joined together; for example, DNA comprising an animal gene may be recombined with DNA from a bacterium.
Synthetic Nucleic Acid Molecules, or DNA or RNA derived from synthetic nucleic acid molecules, that meet any one of the following criteria:
- Contain more than 100 nucleotides; or
- Possess biological properties that enable integration into the genome (e.g., cis elements involved in integration); or
- Have the potential to replicate in a cell; or
- Can be translated or transcribed. [Section III-C].
For additional information, please click on the link below.
Does My Work Require IBC Approval? |
|
|
 |
All research personnel that will be engaged in conducting research with recombinant or Synthetic Nucleic Acid are required to complete the CITI Online ‘Biosafety & Biosecurity’ Course.
Instructions to Sign Up for CITI Online IBC Training |
|
|
 |
The Investigator is required to follow guidelines set forth by the NIH and the IBC in conducting research with recombinant or Synthetic Nucleic Acid.
Access IBC Regulations, Policies & Procedures |
|
|
 |
FIU IBC applications need to be submitted through the online TOPAZ Electronic Protocol Application System.
Investigators should complete one of the following forms:
- IBC Approval Form (For obtaining approval on research conducted with Recombinant or Synthetic Nucleic Acid Molecules that are not exempt)
- IBC Exemption Form (For obtaining exempt review)
Information on the TOPAZ Electronic Protocol Application System |
|
|
 |
- Admin Review: Your submission is first pre-evaluated by the IBC Coordinator for completeness.
- Pre-Review: The IBC looks over the application prior to the Full Board Meeting. The Members have the opportunity to request clarification prior to the meeting. This ensures a more timely review process.
- Designated Review: Exempt protocol applications. This review will normally take at least 5 business days, but can vary depending on the complexity of the submission and the current workload of submissions. In addition, a request for revisions can be made and will require the PI to address.
- Full Board Review: If it is determined that Full Board Review is necessary, the protocol will be placed on a meeting agenda. You should expect the Full Board process to take at least 1 month.
- Final Approval: You will need to wait until you receive an email containing the final approval letter before you can begin your research.
Access the TOPAZ online protocol application system |